» Articles » PMID: 19468777

Alternatives to Animal Experimentation for Hormonal Compounds Research

Overview
Journal Genes Nutr
Publisher Biomed Central
Date 2009 May 27
PMID 19468777
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Alternatives to animal testing and the identification of reliable methods that may decrease the need for animals are currently the subject of intense investigation worldwide. Alternative testing procedures are particularly important for synthetic and natural chemicals that exert their biological actions through binding nuclear receptors, called nuclear receptors-interacting compounds (NR-ICs), for which research is increasingly emphasizing the limits of several models in the accurate estimation of the physiological consequences of exposure to these compounds. In particular, estrogen receptor interacting compounds (ER-ICs) have a great impact on human health from the therapeutic, nutritional, and toxicological point of view due to the highly permissive nature of the estrogen receptors towards a large number of natural and synthetic compounds. Similar to in vitro systems, recently generated animal models (e.g., animal models generated for the study of estrogen receptor ligands) may fulfill the 3R principles: refine, reduce, and replace. If used correctly, NR-regulated models, such as reporter mice, xenopus, or zebrafish, and models obtained by somatic gene transfer in reporter systems, combined with imaging technologies, may contribute to strongly decreasing the overall number of animals required for NR-IC testing and research. With these models, flexible and highly standardized parameters and reporter marker quantification can be obtained. Here, we highlight the need for the substitution of currently used testing models with more appropriate ones that can reproduce the features and reactivity of specific mammalian target tissue/organs. We consider the promotion of this advancement a research priority bearing scientific, economic, social, and ethical relevance.

Citing Articles

Upcyte® microvascular endothelial cells repopulate decellularized scaffold.

Scheller K, Dally I, Hartmann N, Munst B, Braspenning J, Walles H Tissue Eng Part C Methods. 2012; 19(1):57-67.

PMID: 22799502 PMC: 3522132. DOI: 10.1089/ten.TEC.2011.0723.

References
1.
Villa R, Bonetti E, Penza M, Iacobello C, Bugari G, Bailo M . Target-specific action of organochlorine compounds in reproductive and nonreproductive tissues of estrogen-reporter male mice. Toxicol Appl Pharmacol. 2004; 201(2):137-48. DOI: 10.1016/j.taap.2004.05.007. View

2.
Adlercreutz H . Lignans and human health. Crit Rev Clin Lab Sci. 2007; 44(5-6):483-525. DOI: 10.1080/10408360701612942. View

3.
Dukes M . The menopause and the pharmaceutical industry. J Psychosom Obstet Gynaecol. 1997; 18(2):181-8. DOI: 10.3109/01674829709085585. View

4.
Buck Louis G, Gray Jr L, Marcus M, Ojeda S, Pescovitz O, Witchel S . Environmental factors and puberty timing: expert panel research needs. Pediatrics. 2008; 121 Suppl 3:S192-207. DOI: 10.1542/peds.1813E. View

5.
Marchetti M, Caruggi M, Colombo G . Cost utility and budget impact of third-generation aromatase inhibitors for advanced breast cancer: a literature-based model analysis of costs in the Italian National Health Service. Clin Ther. 2004; 26(9):1546-61. DOI: 10.1016/j.clinthera.2004.09.014. View